You Zhi Tong
Net worth: 12 M $ as of 2026-07-30
Net worth: 12 M $ as of 2026-07-30
Dr. You Zhi Tong is a Chairman & Chief Executive Officer at Kintor Pharmaceutical Ltd. and a Chairman & Chief Executive Officer at Suzhou Kintor Pharmaceuticals, Inc. Dr. Tong was previously employed as a Vice President by Angion Biomedica Corp.
He received his undergraduate degree from Peking University, a graduate degree from Peking University and a doctorate degree from Cornell University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-08 | 57,612,770 ( 11.55% ) | 12 M $ | 2026-07-30 |
| Companies | Position | Start |
|---|---|---|
| KINTOR PHARMACEUTICAL LIMITED | Chief Executive Officer | 2009-03-23 |
Suzhou Kintor Pharmaceuticals, Inc.
Suzhou Kintor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treatment of oncological and cardiovascular | Chief Executive Officer | - |
| Companies | Position | End |
|---|---|---|
| ANGN BIOM | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Angion Biomedica Corp.
Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Provides biopharmaceutical products | Health Technology |
Suzhou Kintor Pharmaceuticals, Inc.
Suzhou Kintor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treatment of oncological and cardiovascular | Health Technology |
Kintor Pharmaceutical Ltd.
Kintor Pharmaceutical Ltd. BiotechnologyHealth Technology Provides research and development of prostate, breast & liver cancer drugs services | Health Technology |
Select your edition
All financial news and data tailored to specific country editions